335 related articles for article (PubMed ID: 16306550)
1. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.
Nakamura A; Shikata K; Hiramatsu M; Nakatou T; Kitamura T; Wada J; Itoshima T; Makino H
Diabetes Care; 2005 Dec; 28(12):2890-5. PubMed ID: 16306550
[TBL] [Abstract][Full Text] [Related]
2. Microinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.
Kajitani N; Shikata K; Nakamura A; Nakatou T; Hiramatsu M; Makino H
Diabetes Res Clin Pract; 2010 May; 88(2):171-6. PubMed ID: 20138680
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serum levels of IL-18 in peripheral blood of patients with type II diabetes with nephropathy clinical protests and patients with type II diabetes without nephropathy clinical protests.
Mir M; Rostami A; Hormozi M
Diabetes Metab Syndr; 2017; 11(4):245-250. PubMed ID: 27663212
[TBL] [Abstract][Full Text] [Related]
4. Association Between IL-18 and Carotid Intima-Media Thickness in Patients with Type II Diabetic Nephropathy.
Zhang Y; Feng H; Wei Z
Med Sci Monit; 2017 Jan; 23():470-478. PubMed ID: 28125566
[TBL] [Abstract][Full Text] [Related]
5. Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes.
Aso Y; Okumura K; Takebayashi K; Wakabayashi S; Inukai T
Diabetes Care; 2003 Sep; 26(9):2622-7. PubMed ID: 12941729
[TBL] [Abstract][Full Text] [Related]
6. Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study.
Araki S; Haneda M; Koya D; Sugimoto T; Isshiki K; Chin-Kanasaki M; Uzu T; Kashiwagi A
Diabetologia; 2007 Apr; 50(4):867-73. PubMed ID: 17225121
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy.
Shikano M; Sobajima H; Yoshikawa H; Toba T; Kushimoto H; Katsumata H; Tomita M; Kawashima S
Nephron; 2000 May; 85(1):81-5. PubMed ID: 10773760
[TBL] [Abstract][Full Text] [Related]
8. The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy.
Liu F; Guo J; Zhang Q; Liu D; Wen L; Yang Y; Yang L; Liu Z
PLoS One; 2015; 10(10):e0141471. PubMed ID: 26517838
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
[TBL] [Abstract][Full Text] [Related]
10. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
[TBL] [Abstract][Full Text] [Related]
11. Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes.
Jaffa AA; Durazo-Arvizu R; Zheng D; Lackland DT; Srikanth S; Garvey WT; Schmaier AH;
Diabetes; 2003 May; 52(5):1215-21. PubMed ID: 12716755
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation.
Souza JR; Oliveira RT; Blotta MH; Coelho OR
Arq Bras Cardiol; 2008 Feb; 90(2):86-90. PubMed ID: 18392379
[TBL] [Abstract][Full Text] [Related]
13. Brachial-Ankle Pulse Wave Velocity as a Novel Modality for Detecting Early Diabetic Nephropathy in Type 2 Diabetes Patients.
Zhang X; Bai R; Zou L; Zong J; Qin Y; Wang Y
J Diabetes Res; 2021; 2021():8862573. PubMed ID: 33628837
[TBL] [Abstract][Full Text] [Related]
14. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
[TBL] [Abstract][Full Text] [Related]
15. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M
Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
[TBL] [Abstract][Full Text] [Related]
16. Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes.
Ninomiya H; Katakami N; Sato I; Osawa S; Yamamoto Y; Takahara M; Kawamori D; Matsuoka TA; Shimomura I
J Atheroscler Thromb; 2018 Dec; 25(12):1274-1284. PubMed ID: 29962379
[TBL] [Abstract][Full Text] [Related]
17. Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes.
von Eynatten M; Liu D; Hock C; Oikonomou D; Baumann M; Allolio B; Korosoglou G; Morcos M; Campean V; Amann K; Lutz J; Heemann U; Nawroth PP; Bierhaus A; Humpert PM
Diabetes; 2009 Sep; 58(9):2093-9. PubMed ID: 19509019
[TBL] [Abstract][Full Text] [Related]
18. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
19. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
Klein RL; Hunter SJ; Jenkins AJ; Zheng D; Semler AJ; Clore J; Garvey WT;
Diabetes Care; 2003 May; 26(5):1439-48. PubMed ID: 12716802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
